Xeris Biopharma Holdings Inc (XERS)
3.085
+0.04
(+1.48%)
USD |
NASDAQ |
Nov 22, 16:00
3.085
0.00 (0.00%)
After-Hours: 18:18
Xeris Biopharma Holdings Total Liabilities (Quarterly): 349.43M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 349.43M |
| June 30, 2024 | 351.02M |
| March 31, 2024 | 345.79M |
| December 31, 2023 | 329.38M |
| September 30, 2023 | 323.92M |
| June 30, 2023 | 315.14M |
| March 31, 2023 | 291.31M |
| December 31, 2022 | 299.34M |
| September 30, 2022 | 247.98M |
| June 30, 2022 | 244.67M |
| March 31, 2022 | 241.17M |
| December 31, 2021 | 209.13M |
| September 30, 2021 | 133.72M |
| June 30, 2021 | 131.61M |
| Date | Value |
|---|---|
| March 31, 2021 | 123.25M |
| December 31, 2020 | 125.39M |
| September 30, 2020 | 156.05M |
| June 30, 2020 | 141.43M |
| March 31, 2020 | 89.39M |
| December 31, 2019 | 94.55M |
| September 30, 2019 | 84.44M |
| June 30, 2019 | 59.10M |
| March 31, 2019 | 53.87M |
| December 31, 2018 | 44.62M |
| September 30, 2018 | 42.47M |
| June 30, 2018 | 28.92M |
| March 31, 2018 | 28.71M |
| December 31, 2017 | 102.83M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
89.39M
Minimum
Mar 2020
351.02M
Maximum
Jun 2024
227.18M
Average
242.92M
Median
Total Liabilities (Quarterly) Benchmarks
| Zevra Therapeutics Inc | 121.78M |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
| iBio Inc | 6.763M |
| Theriva Biologics Inc | 15.47M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 321.10M |
| Shareholders Equity (Quarterly) | -28.32M |
| Debt to Equity Ratio | -8.166 |
| Current Ratio | 1.789 |
| Net Debt Paydown Yield | -2.03% |